Featured Research

from universities, journals, and other organizations

Selected cells from blood or bone marrow may provide a route to healing blood vessels

Date:
August 13, 2010
Source:
Emory University
Summary:
When envisioning cell therapy for cardiovascular disease, a team of scientists is focusing on cells that nourish blood vessels, rather than on rare stem cells. In experiments with mice, CD31 positive cells from the blood or bone marrow can effectively treat hindlimb ischemia -- a model of peripheral artery disease. This approach has the potential to be safer and less arduous than experimental therapies involving the isolation of stem cells from bone marrow.

Isolating cells from a patient's blood or bone marrow that nourish blood vessels may be a safer and less arduous route to treatment of cardiovascular disease than obtaining rare stem cells, according to research from Emory University School of Medicine.

In recent clinical trials, doctors in several countries have tested the ability of a patient's bone marrow cells to repair damage, such as heart attacks and peripheral artery disease, created by problems of blood flow.

"The focus has been on stem cells, but it looks like the main beneficial effects come from transplanted cells' ability to support the growth of nearby blood vessels," says senior author Young-sup Yoon, MD, PhD, associate professor of medicine (cardiology) at Emory University School of Medicine. "Based on this idea, we wanted to identify a population of cells enriched with the capacity to regenerate blood vessels."

The blood vessel-repairing properties of selected cells from human blood were described in the Aug. 10 issue of the Journal of the American College of Cardiology, with a related paper on cells derived from mouse bone marrow published online July 15 by the journal Circulation Research.

The first author of the JACC paper is postdoctoral fellow Sung-Whan Kim, PhD. The first author of the Circulation Research paper is Hyongbum Kim, MD, PhD, now an assistant professor in Korea.

Yoon's team focused on the molecule CD31, also known as platelet endothelial cell adhesion molecule-1 or PECAM-1, because of its presence on endothelial cells -- the cells that form the inner lining of blood vessels. In experiments with donated blood from human volunteers or mouse bone marrow cells, the researchers showed that cells with CD31 on their surfaces secrete hormones that support the growth of blood vessels.

About a third of the cells in the blood or bone marrow have CD31 on their surfaces, including some differentiated immune cells. In culture, sorted cells displaying CD31 can form tubular structures mimicking the growth of blood vessels in the body.

"We can show that after transplantation, some CD31 positive cells do become endothelial cells, but their main effect is more to support other cells than to become the building blocks," Yoon says.

The researchers used antibodies against CD31 to sort human blood or mouse bone marrow cells into two groups: cells with CD31 and those without. They then tested these cells' ability to spur blood vessel regrowth in mice whose hind legs had a blocked blood supply.

In the project described in Circulation Research, after two weeks more than 80 percent of the mouse hind legs transplanted with CD31 positive bone marrow cells survived, while less than 15 percent of the legs transplanted with CD31 negative cells survived. In laser Doppler images, the mice with CD31 positive cells injected into their legs had greatly enhanced blood flow and an increased number of capillaries.

Yoon says harvesting CD31 positive cells may have several advantages compared to previous methods of treating cardiovascular disease. The cells can be prepared without the need to grow them in a dish for several days, and it may not be necessary to take large volumes of blood or bone marrow from the patient -- an advantage with respect to safety. In addition, cells from mice used to simulate atherosclerosis (mutant for a gene that helps clear fat from the blood and given a high-fat diet) do not seem to lose their repair potential.

"Based on the insights gained from preclinical and clinical studies from several investigators, we view the use of CD31 positive cells as a second-generation cardiovascular cell therapy that could be a novel option for the treatment of peripheral artery disease," Yoon says.

He adds that CD31 positive cells may have potential for treating other conditions, including heart attack, heart failure and diabetic neuropathy, which his team is investigating in animal models.

The research was supported by the National Institutes of Health, the Department of Defense and the Korean Ministry of Education, Science and Technology.


Story Source:

The above story is based on materials provided by Emory University. The original article was written by Quinn Eastman. Note: Materials may be edited for content and length.


Journal References:

  1. S.W. Kim, H. Kim, H.J. Cho, J.U. Lee, R. Levit, and Y. Yoon. Human Peripheral Blood-Derived CD31 Cells Have Robust Angiogenic and Vasculogenic Properties and Are Effective for Treating Ischemic Vascular Disease. Journal of the American College of Cardiology, 2010; 56 (7): 593 DOI: 10.1016/j.jacc.2010.01.070
  2. H. Kim, H.-J. Cho, S.-W. Kim, B. Liu, Y. J. Choi, J. Lee, Y.-D. Sohn, M.-Y. Lee, M. A. Houge, Y.-S. Yoon. CD31 Cells Represent Highly Angiogenic and Vasculogenic Cells in Bone Marrow. Novel Role of Nonendothelial CD31 Cells in Neovascularization and Their Therapeutic Effects on Ischemic Vascular Disease. Circulation Research, 2010; DOI: 10.1161/CIRCRESAHA.110.218396

Cite This Page:

Emory University. "Selected cells from blood or bone marrow may provide a route to healing blood vessels." ScienceDaily. ScienceDaily, 13 August 2010. <www.sciencedaily.com/releases/2010/08/100813090453.htm>.
Emory University. (2010, August 13). Selected cells from blood or bone marrow may provide a route to healing blood vessels. ScienceDaily. Retrieved July 28, 2014 from www.sciencedaily.com/releases/2010/08/100813090453.htm
Emory University. "Selected cells from blood or bone marrow may provide a route to healing blood vessels." ScienceDaily. www.sciencedaily.com/releases/2010/08/100813090453.htm (accessed July 28, 2014).

Share This




More Health & Medicine News

Monday, July 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Trees Could Save More Than 850 Lives Each Year

Trees Could Save More Than 850 Lives Each Year

Newsy (July 27, 2014) A national study conducted by the USDA Forest Service found that trees collectively save more than 850 lives on an annual basis. Video provided by Newsy
Powered by NewsLook.com
Google's Next Frontier: The Human Body

Google's Next Frontier: The Human Body

Newsy (July 27, 2014) Google is collecting genetic and molecular information to paint a picture of the perfectly healthy human. Video provided by Newsy
Powered by NewsLook.com
What's To Blame For Worst Ebola Outbreak In History?

What's To Blame For Worst Ebola Outbreak In History?

Newsy (July 27, 2014) A U.S. doctor has tested positive for the deadly Ebola virus, as the worst-ever outbreak continues to grow. Video provided by Newsy
Powered by NewsLook.com
Losing Sleep Leaves You Vulnerable To 'False Memories'

Losing Sleep Leaves You Vulnerable To 'False Memories'

Newsy (July 27, 2014) A new study shows sleep deprivation can make it harder for people to remember specific details of an event. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins